UK Offering $7.7M to Capitalize on Genomics | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – A new UK initiative will invest up to £5 million ($7.7 million) in grants to businesses conducting research that use high-throughput sequencing and other genomics technologies, the UK's Technology Strategy Board said Thursday.
The TSB is a business-led public entity that was established by the government to fund research that seeks to develop and exploit technologies and innovations that can boost economic growth and improve life.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.

Feb
23
Sponsored by
NuGEN

This webinar will discuss a project that sought to understand the parent-of-origin epigenetic mechanisms that regulate seed development in plants, with a particular emphasis on differentiating the maternal or paternal origin of epigenetics marks.

Mar
02
Sponsored by
VelaDx

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV.